Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 3:42 pm Sale | 2026-03-13 | 13G | Apogee Therapeutics, Inc. APGE | VANGUARD GROUP INC | 0 0.000% | -2,857,824 (Position Closed) | Filing History |
| 2026-03-06 12:57 pm Purchase | 2026-02-28 | 13G | Apogee Therapeutics, Inc. APGE | T. Rowe Price Investment Management, Inc. | 6,213,827 11.300% | 6,213,827 (New Position) | Filing History |
| 2026-02-17 08:27 am Unchanged | 2025-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RTW INVESTMENTS LP | 2,712,097 4.900% | 0 (Unchanged) | Filing History |
| 2026-02-10 11:23 am Sale | 2025-12-31 | 13G | Apogee Therapeutics, Inc. APGE | WELLINGTON MANAGEMENT GROUP LLP | 4,746,585 8.700% | -138,561 (-2.84%) | Filing History |
| 2026-01-30 1:28 pm Purchase | 2025-12-31 | 13G | Apogee Therapeutics, Inc. APGE | VANGUARD GROUP INC | 2,857,824 5.210% | 2,857,824 (New Position) | Filing History |
| 2026-01-22 8:00 pm Purchase | 2026-01-22 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 6,047,027 9.990% | 270,146 (+4.68%) | Filing History |
| 2025-11-14 07:27 am Purchase | 2025-09-30 | 13G | Apogee Therapeutics, Inc. APGE | DRIEHAUS CAPITAL MANAGEMENT LLC | 2,158,502 4.680% | 2,158,502 (New Position) | Filing History |
| 2025-10-14 7:11 pm Purchase | 2025-10-10 | 13D | Apogee Therapeutics, Inc. APGE | Fairmount Funds Management LLC | 5,776,881 9.990% | 5,776,881 (New Position) | Filing History |
| 2025-08-06 11:51 am Purchase | 2025-06-30 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 6,907,100 15.000% | 6,907,100 (New Position) | Filing History |
| 2025-08-05 1:44 pm Purchase | 2025-07-31 | 13G | Apogee Therapeutics, Inc. APGE | WELLINGTON MANAGEMENT GROUP LLP | 4,885,146 10.600% | 1,079,436 (+28.36%) | Filing History |
| 2025-08-05 1:35 pm Sale | 2025-06-30 | 13G | Apogee Therapeutics, Inc. APGE | WELLINGTON MANAGEMENT GROUP LLP | 3,805,710 8.300% | -1,680,044 (-30.63%) | Filing History |
| 2025-07-16 7:02 pm Purchase | 2025-06-30 | 13G | Apogee Therapeutics, Inc. APGE | BlackRock Inc. BLK | 2,518,725 5.500% | 2,518,725 (New Position) | Filing History |
| 2025-05-12 10:44 am Purchase | 2025-03-31 | 13G | Apogee Therapeutics, Inc. APGE | WELLINGTON MANAGEMENT GROUP LLP | 5,485,754 11.900% | 5,485,754 (New Position) | Filing History |
| 2025-02-14 09:00 am Purchase | 2024-12-31 | 13G | Apogee Therapeutics, Inc. APGE | RTW INVESTMENTS LP | 2,712,097 6.000% | 2,712,097 (New Position) | Filing History |
| 2024-11-14 5:46 pm Unchanged | 2024-11-14 | 13G | Apogee Therapeutics, Inc. APGE | RA CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 11:16 am Unchanged | 2024-11-14 | 13G | Apogee Therapeutics, Inc. APGE | DRIEHAUS CAPITAL MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-14 10:18 am Unchanged | 2024-11-14 | 13G | Apogee Therapeutics, Inc. APGE | Deep Track Capital, LP | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-12 09:50 am Unchanged | 2024-11-12 | 13G | Apogee Therapeutics, Inc. APGE | FMR LLC | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-11-08 | 13G | Apogee Therapeutics, Inc. APGE | BlackRock Inc. BLK | 0 0.000% | 0 (Unchanged) | Filing |
| 2024-11-04 7:59 pm Unchanged | 2024-11-04 | 13G | Apogee Therapeutics, Inc. APGE | ACCESS INDUSTRIES MANAGEMENT LLC | 0 0.000% | 0 (Unchanged) | Filing |